{
    "nct_id": "NCT03456843",
    "official_title": "SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer",
    "inclusion_criteria": "* Histologically proven adenocarcinoma of the prostate\n* Evidence of metastasis by magnetic resonance imaging (MRI)/computed tomography (CT) scan, bone scan, or histologic confirmation\n* Clinical stage M1a (distant lymph node positive), M1b (bone metastasis), or M1c (solid organ metastasis.\n* If solitary lesion, metastasis confirmed with either biopsy or two independent imaging modalities (i.e. CT and PET [positron emission tomography], bone scan and MRI, modality at the discretion of the treating physician)\n* No previous local therapy for prostate cancer (i.e prostate radiation, cryotherapy, etc.)\n* Give informed consent\n* Prostate deemed resectable by surgeon\n* Plans to start or has already started antiandrogen therapy (ADT) no longer than 6 months prior to consent\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n* Hemoglobin (HgB) >= 9 g/dL compatible for surgery\n* Platelets > 80,000/mcL compatible for surgery\n* Aspartate aminotransferase (AST) =< 2x upper limit of normal (ULN) compatible for surgery\n* Alanine aminotransferase (ALT) =< 2x upper limit of normal (ULN) compatible for surgery\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Refuses to give informed consent\n* Deemed to have unresectable disease by surgeon\n* Received ADT for more than 6 months prior to consent\n* Life expectancy of less than 6 months prior to consent\n* Active spinal cord compression\n* Deep vein thrombosis (DVT) / pulmonary embolism (PE) in the past 6 months prior to consent\n* Previous local therapy for prostate cancer\n* Patients who have chemotherapy or radiotherapy for non-prostate cancer related treatment within 3 weeks prior to consent",
    "miscellaneous_criteria": ""
}